Complete integration of inpatient and outpatient burn care: Evolution of an outpatient burn clinic

Journal of Burn Care and Rehabilitation

Volumn 19, Issue 5, 1998, Pages 406-408

  Brandt, Christopher P ^a   Yurko, Lynn ^a   Coffee, Tammy ^a   Fratianne, Richard ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURN; CONSULTATION; HEALTH CARE FACILITY; HOSPITAL CARE; HUMAN; LENGTH OF STAY; MEDICAL STAFF; OUTPATIENT CARE;

BURN UNITS; BURNS; COST CONTROL; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; LENGTH OF STAY; OHIO; OUTPATIENT CLINICS, HOSPITAL;

EID: 0031714462     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199809000-00009     Document Type: Article

References (31)

1. Bernstein J. Capsaicin and substance P. Clin Dermatol 1992;9:497-503.
2. Davis KD, Meyer RA, Turnquist JL, Filloon TG, Pappagallo M, Campbell JN. Cutaneous pretreatment with the capsaicin analog NE-21610 prevents the pain to a burn and subsequent hyperalgesia. Pain 1995;62:373-8.
3. Dray A. Neuropharmacological mechanisms of capsaicin and related substances. Biochem Pharmacol 1992;44:611-5.
4. Jessell TM, Iversen LL, Cuello AC. Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res 1978;152:183-8.
5. Takeuchi K, Ueshima K, Ohuchi T, Okabe S. The role of capsaicin-sensitive sensory neurons in healing of HCL-induced gastric mucosal lesions in rats. Gastroenterology 1994;106:1524-32.
6. Takeuchi K, Ohuchi T, Okabe S. Capsaicin-sensitive sensory neurons in healing gastric lesions induced by HCL in rats. Dig Dis Sci 1994;39:2534-46.
7. Gallar J, Pozo M, Rebollo I, Belmonte C. Effects of capsaicin on corneal wound healing. Invest Opthalmol Vis Sci 1990;31:1968-74.
8. Kjartansson J, Dalsgaard CJ, Jonsson CE. Decreases survival of experimental critical flaps in rats after sensory denervation with capsaicin. Plast Reconstr Surg 1987;79:218-20.
9. Maggi CA, Borsini F, Santicioli P, Geppeetti P, Abelli L, Evangelista S, et al. Cutaneous lesions in capsaicin-pretreated rats: a trophic role of capsaicin-sensitive afferents? Naunyn Schmiedebergs Arch Pharmacol 1987;336:538-45.
10. Dunnick CA, Gibran NS, Heimbach DM. Substance P has a role in neurogenic mediation of human burn wound healing. J Burn Care Rehabil 1996;17:390-6.
11. Chiba T, Masuko S, Kawano H. Correlation of mitochondrial swelling after capsaicin treatment and substance P and somatostatin immunoreactivity in small neurons of dorsal root ganglion in the rat. Neurosci Lett 1986;64:311-6.
12. Yagi T. Inhibition by capsaicin of NADH-quinone oxidore-ductases is correlated with the presence of energy-coupling site 1 in various organisms. Arch Biochem Biophys 1990;281:305-11.
13. Ziehe M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 1990;40:264-78.
14. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979;310:175-83.
15. Payan DG. Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. Biochem Biophys Res Commun 1985;130:104-9.
16. Nilsson J, von Euler A, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985;315:61-3.
17. Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988;90:399-401.
18. Hartung HP, Toyka KV. Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol 1983;89:301-5.
19. Santoni G, Perfumi M, Bressan AM, Piccoli M. Capsaicin-induced inhibition of mitogen and interleukin-2-stimulated T cell proliferation: its reversal by an in vivo substance P administration. J Neuroimmunol 1996;68:131-8.
20. Helme RD, Andrews PV. The effect of nerve lesions on the inflammatory response to injury. J Neurosci Res 1985;13:453-9.
21. Helme RD, Eglezos A, Hosking CS. Substance P induces chemotaxis of neutrophils in normal and capsaicin-treated rats. Immunol Cell Biol 1987;3:267-9.
22. Watcher MA, Wheeland RG. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 1989;15:1188-95.
23. McCauley RL, Linares HA, Pelligrini V, Herndon DN, Robson MC, Heggers JP. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res 1989;46:267-74.
24. McCauley RL, Li YY, Poole B, Evans MJ, Robson MC, Heggers JP, et al. Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res 1992;52:276-85.
25. Geronemus RG, Mertz PM, Eaglstein WH. The effects of topical antimicrobial agents. Arch Dermatol 1979;115:1311-4.
26. Bishop JB, Phillips LG, Mustoe TA, VanderZee AJ, Wiersema L, Roach D, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg 1992:16:251-7.
27. Penneys NS. Inhibition of arachidonic acid oxidation in vitro by vehicle components. Acta Derm Venereol 1982;62:59-61.
28. DelBarccaro E, Robson MC, Heggers JP, Swaminathan R. The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning. Surgery 1980;87:137-41.
29. Robson MC. The immediate and delayed cellular damage following soft tissue trauma. In: Zarins CK, editor. Essays in surgery. New York: Churchill Livingstone; 1989. p. 153-8.
30. Sifton DW, editor. Physician's desk reference. Montvale (NJ): Medical Economics; 1997. p. 1043.
31. Eaglstein WH, Mertz PM. "Inert" vehicles do affect wound healing. J Invest Dermatol 1980;74:90-1.